[Use of thymalin in the complex treatment of infantile cerebral palsy].
Mamonova. I P IP
Key Findings
- Thymalin was added to a standard rehab program for children with spastic diplegia.
- Immune system parameters were tracked before and after the 1‑month treatment.
- 54.55% of the children showed measurable neurological improvement after the month.
Practical Outcomes
- For DIY health enthusiasts, this study offers very limited, indirect insight: thymalin might have modest immune‑modulating or neuro‑protective effects, but the evidence is from a tiny pediatric trial and not directly applicable to adult longevity or performance goals. More robust research is needed before considering it in personal protocols.
Summary
A small study gave the peptide thymalin to 22 kids with spastic cerebral palsy and frequent infections, alongside their usual rehab. After a month, about half of the children showed some neurological improvement, and immune markers were measured before and after treatment.
Abstract
The immunomodulator thymalin was included in the complex of rehabilitative therapy of 22 children with cerebral paralysis expressed in the form of spastic diplegia and with frequent intercurrent infections. Immunological parameters were measured before and after treatment to determine the efficiency of the therapy. Improvement in the neurological defect was observed in 54.55% of children with an impaired function of the immunocompetent system one month after the treatment.
Study Information
pubmed
1985